Skip Ribbon Commands
Skip to main content

Our Core Business

SingHealth Investigational Medicine Unit (IMU) is a dedicated early phase clinical research unit, which supports the research of commercial partners and independent investigators.

Its projects are supported by a team of dedicated staff comprising clinical research coordinators, clinical research nurses, trained in Good Clinical Practice (ICH-GCP). Located within Singapore General Hospital, SingHealth IMU specialises in diseases that impact patients in Asia, including oncology, haematology, cardiology, gastroenterology, infectious disease and endocrinology.

Image Contact Icon.png(65) 6323 7532 / 6323 7544 Image_Email Icon.pngimu@singhealth.com.sg

Tailored Medical Specialities
SingHealth IMU offers tailored services to its research partners, including:
• Specimen collection, handling and processing
• Coordination with external central laboratories
• Project management of trials
• Preparation for external audit and inspection
• Conduct of trials adhering to ICH-GCP and SingHealth Centralised Institutional Review Board (CIRB) guidelines

Ready access to a wide range of research services

Image_ Wide range of Research Activities (Slide no. 4).jpg

Here in SingHealth IMU, we have established links with other research services under the SingHealth Group, including but not limited to: 

• PET, CT and MRI facilities

• Nuclear medicine services

• Animal research facilities for pre-clinical work

• Biobanking services

• Investigational and chemotherapy pharmacy services

• A kitchen service, which can provide metabolic diets for feed-controlled studies

• CAP-certified pathology laboratories